Safety and Efficacy Study of New Eye Drop Formulations With Refresh Tears® in Patients With Dry Eye Disease

NCT01294384 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

305

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye Syndromes

Interventions

DRUG: carboxymethylcellulose sodium based New Eye Drop Formulation 1
DRUG: carboxymethylcellulose sodium based New Eye Drop Formulation 2
DRUG: carboxymethylcellulose sodium based Eye Drops

Sponsor

Allergan